Annual report pursuant to Section 13 and 15(d)

Balance Sheet Components (Tables)

v3.24.1
Balance Sheet Components (Tables)
 12 Months Ended
Dec. 31, 2023
Balance Sheet Components [Abstract]  
Schedule of Prepaid Expenses and Other Current Assets Prepaid expenses and other current assets as of December 31, 2022 and 2023 consisted of the following (in thousands):
    As of     As of  
    December 31,     December 31,  
    2022     2023  
Prepaid directors’ and officers’ liability insurance premiums   $           476     $ 270  
Prepaid preclinical services     1,554       3,103  
Other     159       325  
Total   $ 2,189     $ 3,698  
Schedule of Property, Plant and Equipment Property, plant and equipment as of December 31, 2022 and 2023 consisted of the following (in thousands):
    As of     As of  
    December 31,     December 31,  
    2022     2023  
Leasehold improvements   $         15     $ 21  
Furniture and fixtures     14       21  
Subtotal     29       42  
Less accumulated depreciation     (7 )     (16 )
Net   $ 22     $ 26  

 
Schedule of Accounts Payable Accounts payable as of December 31, 2022 and 2023 consisted of the following (in thousands):
    As of     As of  
    December 31,     December 31,  
    2022     2023  
Trade accounts payable   $        846     $ 821  
Credit card liability     46       18  
Total   $ 892     $ 839  
Schedule of Accrued Liabilities Accrued liabilities as of December 31, 2022 and 2023 consisted of the following (in thousands):
    As of     As of  
    December 31,     December 31,  
    2022     2023  
Accrued labor costs   $       1,487     $ 1,917  
Accrued drug development costs     228       1,034  
Other     522       283  
Total   $ 2,237     $ 3,234